EFFECTS OF METHANOL LEAF EXTRACT OF MORINGA OLEIFERA ON NEUROBEHAVIOURAL AND OXIDATIVE STRESS CHANGES INDUCED BY SUBCHRONIC EXPOSURE TO CHLORPYRIFOS IN MALE WISTAR RATS

 

Table Of Contents


  • <p>&nbsp;                <b>TABLE OF CONTENTS&nbsp;</b></p><p>Declaration....................................................................................................................... iii&nbsp;</p><p>Certification ..................................................................................................................... iv&nbsp;</p><p>Dedication......................................................................................................................... v&nbsp;</p><p>Acknowledgments ........................................................................................................... vi&nbsp;</p><p>Abstract........................................................................................................................... vii&nbsp;</p><p>Table of Contents............................................................................................................. ix&nbsp;</p><p>List of Tables................................................................................................................. xiv&nbsp;</p><p>List of Figures................................................................................................................. xv&nbsp;</p><p>List of Plates ................................................................................................................. xvii&nbsp;</p><p>List of Abbreviations................................................................................................... xviii&nbsp;</p><p>

Chapter ONE

INTRODUCTION

  • ........................................................................... 1&nbsp;</p><p>
  • 1.1Background ......................................................................................................... 1&nbsp;</p><p>
  • 1.2Statement of Research Problem ........................................................................ 3&nbsp;</p><p>
  • 1.3Justification ......................................................................................................... 5&nbsp;</p><p>
  • 1.4General Aim of the Study................................................................................... 6&nbsp;</p><p>
  • 1.5Objectives of the Study....................................................................................... 6&nbsp;</p><p>
  • 1.6Research Hypothesis (H0)................................................................................... 7&nbsp;</p><p>

Chapter TWO

LITERATURE REVIEW

  • .............................................................. 8&nbsp;</p><p>
  • 2.1Pesticides.............................................................................................................. 8&nbsp;</p><p>2.
  • 1.1Classification of pesticides ................................................................................... 8&nbsp;</p><p>
  • 2.2Organophosphates.............................................................................................. 9&nbsp;</p><p>2.
  • 2.1Classification of organophosphates...................................................................... 9&nbsp;</p><p>2.
  • 2.2History of organophosphates.............................................................................. 10&nbsp;</p><p>2.
  • 2.3Uses of organophosphates .................................................................................. 11&nbsp;</p><p>2.
  • 2.4Mechanism of action of organophosphates ........................................................ 12&nbsp;</p><p>2.
  • 2.5Organophosphate toxicity................................................................................... 13&nbsp;</p><p>
  • 2.3Chlorpyrifos ...................................................................................................... 19&nbsp;</p><p>2.
  • 3.1Pharmacodynamics of chlorpyrifos.................................................................... 20&nbsp;</p><p>2.
  • 3.2Pharmacokinetics of chlorpyrifos....................................................................... 20&nbsp;</p><p>2.
  • 3.3Chlorpyrifos toxicity........................................................................................... 22&nbsp;</p><p>
  • 2.4Formation and Action of Reactive Oxygen Species....................................... 29&nbsp;</p><p>2.
  • 4.1Effects of free radicals on biological systems .................................................... 31&nbsp;</p><p>
  • 2.5Antioxidants and their Defence System.......................................................... 33&nbsp;</p><p>2.
  • 5.1Antioxidants........................................................................................................ 33&nbsp;</p><p>2.
  • 5.2Antioxidant defence system................................................................................ 35&nbsp;</p><p>
  • 2.6Oxidative Stress - a Mechanism of Chlorpyrifos Toxicity ............................ 36&nbsp;</p><p>
  • 2.7Moringa oleifera ................................................................................................ 38&nbsp;</p><p>2.
  • 7.1Moringa oleifera: description ............................................................................. 38&nbsp;</p><p>2.
  • 7.2Nutritional properties and ethnomedical uses of Moringa oleifera.................... 39&nbsp;</p><p>2.
  • 7.3Antioxidant properties of Moringa oleifera........................................................ 40&nbsp;</p><p>

Chapter THREE

RESEARCH METHODOLOGY

  • MATERIALS AND METHODS ............................................ 42&nbsp;</p><p>
  • 3.1Plant Materials.................................................................................................. 42&nbsp;</p><p>3.
  • 1.1Plant collection, identification, extraction and preparation ................................ 42&nbsp;</p><p>3.
  • 1.2Phytochemical screening of leaf extract ............................................................. 42&nbsp;</p><p>3.
  • 1.3Quantitative analysis of methanol extract of Moringa oleifera leaf for flavonoids and antioxidant vitamins..................................................................................... 43&nbsp;</p><p>
  • 3.2Chemical Acquisition and Preparation .......................................................... 43&nbsp;</p><p>
  • 3.3LD50 Determination .......................................................................................... 43&nbsp;</p><p>
  • 3.4Experimental Animals...................................................................................... 44&nbsp;</p><p>
  • 3.5Experimental Groupings/Treatments............................................................. 44&nbsp;</p><p>
  • 3.6Evaluation of neurobehavioural and cognitive changes................................ 45&nbsp;</p><p>3.
  • 6.1Open-field assessment ........................................................................................ 45&nbsp;</p><p>3.
  • 6.2Assessment of neuromuscular coordination …………………………………….…...46&nbsp;</p><p>3.
  • 6.3Assessment of motor coordination ..................................................................... 46&nbsp;</p><p>3.
  • 6.4Assessment of locomotor efficiency................................................................... 47&nbsp;</p><p>3.
  • 6.5Assessment of motor strength............................................................................. 47&nbsp;</p><p>3.
  • 6.6Assessment of excitability score......................................................................... 47&nbsp;</p><p>3.
  • 6.7Assessment of depression ................................................................................... 48&nbsp;</p><p>3.
  • 6.8Evaluation of learning and short-term memory.................................................. 48&nbsp;</p><p>
  • 3.7Preparation of Brain Samples ......................................................................... 49&nbsp;</p><p>
  • 3.8Assessment of Acetylcholinesterase Activity .................................................. 49&nbsp;</p><p>
  • 3.9Assessment of Brain Lipoperoxidation........................................................... 50&nbsp;</p><p>
  • 3.10Assessment of Brain Antioxidant Enzyme Activities .................................... 50&nbsp;</p><p>
  • 3.11Histopathology .................................................................................................. 51&nbsp;</p><p>
  • 3.12Data Analysis..................................................................................................... 52&nbsp;</p><p>

Chapter FOUR

DATA PRESENTATION AND ANALYSIS

  • RESULTS.................................................................................... 53&nbsp;</p><p>
  • 4.1Determination of Median Lethal Dose............................................................ 53&nbsp;</p><p>4.
  • 1.1Determination of median lethal dose for chlorpyrifos........................................ 53&nbsp;</p><p>4.
  • 1.2Determination of median lethal dose for Moringa oleifera leaf extract............. 55&nbsp;</p><p>
  • 4.2Moringa oleifera Leaf: Methanol Extract Characteristics............................ 55&nbsp;</p><p>4.
  • 2.1Methanol extract yield of moringa oleifera leaf................................................. 55&nbsp;</p><p>4.
  • 2.2Phytochemical components of methanol extracts of Moringa oleifera leaf....... 55&nbsp;</p><p>4.
  • 2.3Flavonoid and antioxidant vitamin contents of Moringa oleifera leaf extract ... 57&nbsp;</p><p>
  • 4.3Subchronic Toxicity Study............................................................................... 59&nbsp;</p><p>4.
  • 3.1Clinical signs....................................................................................................... 59&nbsp;</p><p>
  • 4.4Effect of Treatments on Neurobehaviour....................................................... 59&nbsp;</p><p>4.
  • 4.1Effect of treatments on open-field performance ................................................. 59&nbsp;</p><p>4.
  • 4.2Effect of treatments on beam-walk score ........................................................... 75&nbsp;</p><p>4.
  • 4.3Effect of treatments on ladder-walk performance .............................................. 77&nbsp;</p><p>4.
  • 4.4Effect of treatments on inclined plane performance........................................... 80&nbsp;</p><p>4.
  • 4.5Effect of treatments on forepaw grip time .......................................................... 82&nbsp;</p><p>4.
  • 4.6Effect of treatments on excitability scores.......................................................... 85&nbsp;</p><p>4.
  • 4.7Effect of treatments on forced swimming test.................................................... 88&nbsp;</p><p>4.
  • 4.8Effect of treatments on learning acqusition ........................................................ 91&nbsp;</p><p>4.
  • 4.9Effect of treatments on short-term memory........................................................ 91&nbsp;</p><p>
  • 4.5Effect of Treatments on Brain Acetylcholinesterase Activity....................... 94&nbsp;</p><p>
  • 4.6Effect of Treatments on Brain Malondialdehyde Concentration................. 94&nbsp;</p><p>
  • 4.7Effect of Treatments on Brain Antioxidant Enzymes ................................... 97&nbsp;</p><p>4.
  • 7.1Effect of treatments on brain superoxide dismutase activity.............................. 97&nbsp;</p><p>4.
  • 7.2Effect of treatments on brain glutathione peroxidase activity ............................ 97&nbsp;</p><p>4.
  • 7.3Effect of treatments on brain catalase activity.................................................... 97&nbsp;</p><p>
  • 4.8Effect of Treatments on Brain Histo-architecture....................................... 102&nbsp;</p><p>

Chapter FIVE

SUMMARY, CONCLUSION AND RECOMMENDATIONS

  • DISCUSSION ............................................................................. 109&nbsp;</p><p>CHAPTER SIX: CONCLUSION AND RECOMMENDATIONS ........................ 130&nbsp;</p><p>
  • 6.1Conclusion ....................................................................................................... 130&nbsp;</p><p>6.
  • 2.Recommendations........................................................................................... 130&nbsp;</p><p>6.
  • 2.1Specific recommendations................................................................................ 130&nbsp;</p><p>6.
  • 2.2General recommendations ................................................................................ 131&nbsp;</p><p>REFERENCES…………………………………………………………………………….……… 132 <br></p>

Project Abstract

<p>&nbsp;                    <b>ABSTRACT&nbsp;</b></p><p>The aim of the study was to investigate the modulatory role of methanol extract of Moringa oleifera leaves (MO) on neurotoxicity induced by chlorpyrifos (CPF) exposure. The methanol extract of the MO leaves were first subjected to qualitative phytochemical screening. The quantity of flavonoids was evaluated using the High performance Liquid Chromatography (HPLC) while vitamins A, C and E were also evaluated using ultraviolet-visible spectroscopy. To investigate the modulatory role of MO leaves on CPF-induced neurotoxicty, 60 male Wistar rats were divided into 6 groups of 10 animals each.Group I was administered with distilled water (2 ml/kg); Group II, with soya oil (2 ml/kg); Group III, with MO (500 mg/kg); and Group IV, with CPF (9.8 mg/kg~1/10th of the LD50 determined). Groups V and VI were administered with MO at 250 mg/kg and 500 mg/kg, respectively, 30 min before administration of CPF (9.8 mg/kg). The regimens were administered once daily via gavage for a period of 9 weeks. Animals were subjected to neurobehavioural tests such as open field (measuring frequency of locomotion, rearing, stretch–attends posture, defaecation and urination), beam-walk (measuring motor coordination), ladder walk, (measuring efficiency of locomotion) inclined plane (measuring neuromuscular coordination), forepaw grip time (measuring motor strength), excitability scores and forced swimming (measuring depression) on day 0, weeks 3, 6 and 9 of administration, and then step-down avoidance test (measuring learning and shortterm memory) at the end of extract administration. Thereafter, the animals were sacrificed and the brain tissues harvested. The homogenates were assayed for levels of acetylcholinesterase (AChE), superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT) and malondialdehyde (MDA). Brain tissue was also processed for histopathological examinations. The phytochemical screening indicated that MO extract was positive for alkaloids, flavonoids, glycosides, phenol, saponin, tannin and terpenoids. Quantitative analysis of the antioxidant components of the plant showed that the flavonoid, vitamins A, C and E contents of the plant were 22.6% w/w, 0.3 mg/g, 6.7 mg/g and 0.22 IU/g, respectively. The result of the subchronic toxicity showed that CPF decreased (P &lt; 0.05) frequency of locomotion and rearing, indicating deficiency of motor activity, and increased (P &lt; 0.05) the frequency of stretch-attends posture and defaecation in the open field, demonstrating anxiogenic response. The CPF induced significant (P &lt; 0.05) deficits in beam-walk score, forepaw grip time, ladder work, forced swimming time and excitability score, while it marginally increased (P &gt; 0.05) the number of foot shocks, but decreased significantly (P &lt; 0.05) the time spent on the platform in the step-down avoidance inhibition apparatus indicating apparent deficits in learning and significant deficit in short-term memory, respectively. The CPF group also showed an increase in brain MDA concentration and reduction in the activities of SOD, GPx but an increase in the activity of CAT, indicating oxidative stress. Histopathology revealed that CPF induced neuronal degeneration. Pretreatment with MO extract mitigated the deficit in motor activity, anxiety, motor coordination, neuromuscular coordination, motor strength, excitability scores, depression, learning and short-term memory provoked by subchronic CPF administration. MO pretreatment modulated the brain AChE activity and mitigated the neuronal degeneration provoked by CPF. MO also mitigated the CPF-induced oxidative stress in the brain by reducing MDA concentration and modulated the activities of SOD, CAT and GPx, demonstrating its antioxidant effect. In conclusion, MO pretreatment mitigated CPF-evoked neurotoxicity due to the flavonoid, vitamins C and E contents of the plant extract, which confers its antioxidant and AChE restorative properties. <br></p>

Project Overview

Blazingprojects Mobile App

📚 Over 50,000 Project Materials
📱 100% Offline: No internet needed
📝 Over 98 Departments
🔍 Software coding and Machine construction
🎓 Postgraduate/Undergraduate Research works
📥 Instant Whatsapp/Email Delivery

Blazingprojects App

Related Research

Anatomy. 3 min read

Comparative Morphological Analysis and 3D Mapping of Lumbar Vertebral Endplates in D...

What This Project Is About The project explores how the lower spine bones (lumbar vertebrae) and their endplates change in degenerative disc disease. It uses tw...

BP
Blazingprojects
Read more →
Anatomy. 2 min read

Three-dimensional mapping of corneal nerve architecture in diabetic versus non-diabe...

What This Project Is About A simple, plain-language look at how corneal nerves differ between people with diabetes and those without, using a high-resolution im...

BP
Blazingprojects
Read more →
Anatomy. 3 min read

3D Assessment of Facial Musculature Activation Patterns Using Muscle Synergy Analysi...

What This Project Is About A plain-language overview of the topic and what the project investigates. The Problem It Addresses What problem or gap this project ...

BP
Blazingprojects
Read more →
Anatomy. 4 min read

Comparative Morphometric Analysis of Autonomic Nerve Plexuses in Pediatric vs. Adult...

What This Project Is About A straightforward, hands-on study that looks at how autonomic nerve networks differ between children and adults using real human tiss...

BP
Blazingprojects
Read more →
Anatomy. 2 min read

Comparative analysis of autonomic innervation patterns in human and non-human primat...

What This Project Is About A straightforward, non-technical overview of studying how autonomic nerves connect to brain regions in humans and non-human primates,...

BP
Blazingprojects
Read more →
Anatomy. 3 min read

Development of a 3D morphometric atlas for age-related degenerative changes in the h...

What This Project Is About A clear, plain-language overview of creating a 3D map (atlas) of knee joints focused on how aging affects structures inside the knee....

BP
Blazingprojects
Read more →
Anatomy. 3 min read

1. Comparative Morphometric Analysis of Orbital Rim and Neurovascular Structures in ...

What This Project Is About A final-year project that looks at how bones, muscles, nerves, and vessels differ among people and how these differences affect funct...

BP
Blazingprojects
Read more →
Anatomy. 4 min read

Advanced 3D Anatomical Modeling and Visualization of the Human Cardiorespiratory Sys...

What This Project Is About A simple, visual project that creates detailed 3D models of the body's heart and lungs using medical images like MRI and CT scans. It...

BP
Blazingprojects
Read more →
Anatomy. 4 min read

1. Comparative Morphology and Functional Correlates of the Pelvic Floor Musculature ...

What This Project Is About A plain-language overview of ten topics in anatomy, focusing on body structure and how different parts work together. It covers pelvi...

BP
Blazingprojects
Read more →
WhatsApp Click here to chat with us